WS #11609
Holding: newest synthesis is 138d old
Vera Therapeutics wins FDA approval for Trutakna kidney disease therapy, a positive catalyst for VERA stock.
Biotech catalyst: Vera Therapeutics FDA approval
Vera Therapeutics wins FDA approval for Trutakna kidney disease therapy, a positive catalyst for VERA stock.